• BRCAness and Olaparib Sensitivity in Mesothelioma

  2026-10-06

  Borchert et al. linked homologous recombination repair gene-expression patterns with olaparib response in malignant pleural mesothelioma models, emphasizing BAP1-associated BRCAness rather than BRCA1/2 status alone. The findings support biomarker-guided investigation of PARP inhibition, but remain exploratory because the evidence comes from a small in vitro panel and retrospective clinical-sample profiling.

• From Colony Maps to Molecular Confidence in PCR

  2026-10-06

  A thought-leadership analysis of how endpoint PCR can support spatial infection research, what the 2026 ambrosia beetle protocol does—and does not—establish, and where the 2X Taq PCR Master Mix (with dye) fits in translational assay strategy.

• Magnetic Stimulation and GABRE in Schizophrenia Models

  2026-10-05

  A 2025 Molecular Psychiatry study identifies the GABAA receptor ε subunit, GABRE, in the left prelimbic cortex as a mechanistically relevant target for selective magnetic stimulation in mice. Its combination of circuit-level stimulation, bidirectional Gabre manipulation, behavioral assessment, and synaptic analysis strengthens the case for GABRE-related signaling in schizophrenia-like phenotypes while leaving important translational questions unresolved.

• (S,S)-Nanaomycin A and DNMT3B in NEPC

  2026-10-05

  Explore how (S,S)-Nanaomycin A is used to investigate DNMT3B-driven lineage plasticity in neuroendocrine prostate cancer. This evidence-focused analysis separates reported preclinical findings from broader therapeutic interpretation and highlights the study’s most important conceptual advance.

• Crystal Violet Staining Solution: Interpreting Endpoints

  2026-10-04

  Crystal Violet Staining Solution is a nuclear staining dye for visualizing retained cellular material across several research assays. This evidence-focused guide explains what the signal can—and cannot—support in proliferation, migration, invasion, and colony formation studies.

• Non-Betalain DODA and Plant Stress Adaptation

  2026-10-03

  A 2025 study shows that VwDODA, a non-betalain DODA homolog from pansy, has a stress-related role rather than a primary pigment-biosynthetic function. The work links VwDODA with altered antioxidant defenses, ABA-associated salt responses, disease resistance, and possible VwMYB20-mediated transcriptional regulation.

• Cyanin Chloride in a Psoriasis Skin-Barrier Model

  2026-10-02

  The 2024 reference study integrates antioxidant screening, macrophage inflammation assays, cytokine-stimulated HaCaT keratinocytes, and epithelial barrier measurements to examine cyanin chloride in a psoriasis-relevant model. Its main contribution is linking reduced inflammatory signaling, STAT3 regulation, TEER recovery, and filaggrin expression while highlighting the need to distinguish the tested glycoside from related cyanidin compounds.

• BjuBRC1-1 and Flowering Control in Brassica juncea

  2026-10-01

  Feng et al. identify BjuBRC1-1 as a short-day-induced TCP transcription factor that delays flowering in Brassica juncea-related systems. Their results connect BjuBRC1 proteins with BjuFT interaction networks and show direct repression of the BjuFUL promoter, providing a layered model for flowering-time regulation.

• MTSEA-biotin for Cysteine Accessibility Mapping

  2026-10-01

  MTSEA-biotin provides a covalent, biotin-based route to investigate accessible cysteines in protein complexes relevant to RNA polymerase II regulation. This article explains how to use the reagent as a complementary assay tool alongside the FeaSion framework, while avoiding overinterpretation of indirect labeling data.

• NAT1–ENO1–Lactate Signaling in Colorectal Cancer

  2026-09-30

  A 2026 MedComm study defines NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its integrated database, multi-omics, patient, cellular, and mouse-model evidence provides a mechanistic framework for understanding how glycolytic metabolism may influence immune-checkpoint response, while also clarifying the limits of translating LDHA-focused experiments into colorectal cancer immunotherapy research.

• Dibutyryl-cAMP, sodium salt for Signaling Studies

  2026-09-30

  Dibutyryl-cAMP, sodium salt provides a practical way to elevate intracellular cAMP while testing PKA-linked responses in cells and brain-relevant models. This workflow-focused guide covers dose design, organotypic slice experiments, neuronal applications, inflammation studies, and troubleshooting for reproducible pathway interpretation.

• Annexin V-HF647/PI Apoptosis Kit in ESCC

  2026-09-29

  The Annexin V-HF647/PI Apoptosis Kit enables a practical, single-cell view of apoptosis during HOXC9 and AKT/mTOR studies in esophageal squamous cell carcinoma. This guide explains assay biology, experimental design, controls, interpretation, and the limits of linking Annexin V/PI results to mitochondrial mechanisms.

• Pemetrexed Workflows for Folate-Pathway Studies

  2026-09-29

  Use Pemetrexed as more than a cytotoxic readout: it is a practical perturbation tool for mapping folate metabolism, nucleotide stress, and DNA-repair vulnerabilities. This workflow-focused guide connects dose-response design with malignant mesothelioma models and translational assay interpretation.

• MLN2238: From β5 Inhibition to Translational Insight

  2026-09-28

  MLN2238 offers a mechanistically defined route into proteasome stress biology, linking β5-centered proteolytic control with apoptosis, resistance research, and ROS–JNK–CREB adaptation. This article translates those insights into a practical framework for oncology and proteostasis researchers.

• Epilepsy-Associated Cardiac Biomarkers in Baboons

  2026-09-28

  A retrospective study in a captive baboon pedigree found prolonged QT and Fridericia-corrected QT intervals in epileptic animals, alongside a non-significant tendency toward lower heart rate variability. The findings support further study of cardiac measures in epilepsy, but do not establish inherited risk or predict sudden unexpected death in epilepsy.

8075 records 1/539 page Next 12345 下5页 Last page